Detalhe da pesquisa
1.
Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells.
Prostate
; 80(14): 1233-1243, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761925